ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
피부염 시장 규모는 최근 꾸준히 확대하고 있습니다. 2025년 70억 6,000만 달러에서 2026년에는 73억 6,000만 달러로, CAGR 4.3%로 성장할 것으로 전망됩니다. 지난 몇 년간의 성장 요인으로는 피부질환의 높은 유병률, 코르티코스테로이드의 보급, 피부과 진료 횟수 증가, 환경적 요인, 항히스타민제 사용 등을 들 수 있습니다.
피부염 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 89억 4,000만 달러에 달하고, CAGR은 5.0%가 될 전망입니다. 예측 기간의 성장 요인으로는 생물학적 제제의 혁신, 오염 관련 피부 질환의 증가, 피부과 클리닉의 확대, 셀프 케어에 대한 인식의 증가, 고령화 사회 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 생물학적 제제 요법의 이용 확대, 외용제 치료에 대한 수요 증가, 면역조절제의 보급 확대, 만성 피부질환에 대한 인식 개선, OTC 피부과 제품의 성장 등을 꼽을 수 있습니다.
피부염 발생률의 증가는 향후 몇 년 동안 피부염 시장 성장을 견인할 것으로 예상됩니다. 피부염은 발적, 가려움증, 자극을 특징으로 하는 염증성 피부질환군을 말하며, 알레르겐, 환경적 요인, 면역반응 또는 유전적 소인에 의해 유발되는 경우가 많습니다. 피부염 환자 증가는 주로 현대 생활에서 환경 알레르겐과 자극 물질에 대한 노출 증가에 기인합니다. 이는 면역체계의 과민반응을 일으켜 피부의 염증과 장벽 기능의 파괴로 이어집니다. 이러한 피부염 사례의 증가는 염증을 줄이고 환자 예후를 개선하기 위한 외용 스테로이드, 칼시뉴린 억제제, 항히스타민제, 보습제, 첨단 생물학적 제제 등 효과적인 치료 옵션에 대한 수요를 증가시켜 시장을 주도하고 있습니다. 예를 들어, 미국 약사협회(미국 약사 전문 단체)가 2025년 3월에 발표한 바에 따르면, 약 3,300만 명의 미국인이 적어도 한 가지 이상의 식품 알레르기를 앓고 있으며, 이는 어린이의 약 8%, 성인의 약 11%에게 영향을 미친다고 합니다. 그 결과, 피부염 유병률의 증가는 피부염 시장의 확대를 뒷받침하고 있습니다.
피부염 시장에서 사업을 전개하는 주요 기업들은 경쟁 우위를 확보하고 제품 포트폴리오를 확장하기 위해 ARCTIVA와 같은 클린 라벨 스테로이드 프리 제품을 개발하고 있습니다. ARCTIVA는 습진, 건선 등의 피부 질환을 관리하기 위해 처방된 스테로이드 프리 스킨케어 제품군으로, 혁신적인 하이드로서프 글리코리피드(Hydrosurf Glycolipid) 기술을 적용했습니다. 예를 들어, 2023년 4월 미국의 클린 라벨 스킨케어 전문 기업 Arctiva Wellness, LLC는 습진, 건선 등 피부 질환을 효과적으로 치료하기 위해 고안된 첨단 비처방, 무스테로이드 스킨케어 솔루션 'ARCTIVA'를 출시했습니다. 이 혁신적인 스킨케어 라인은 최첨단 과학 연구와 동물 실험을 하지 않은 천연 유래 성분, 그리고 임상적으로 검증되고 FDA 승인을 받은 유효 성분을 결합하여 확실한 효과를 보장합니다. 특히 중요한 점은 이 제품 라인은 시장에서 유일하게 혁신적인 하이드로서프 글리콜리피드 기술을 채택하고 있다는 점입니다. 남극 대륙에서 발견한 발효 성분을 독자적으로 블렌딩한 것으로, 뛰어난 스킨케어 효과를 가지고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Dermatitis refers to conditions treated with inhibitors that reduce skin inflammation, which is marked by itchy rashes on swollen, reddish skin on the outer layer of the body. It is a broad term used to describe common skin irritation.
The main types of drugs used in dermatitis include corticosteroids, emollients or moisturizers, antihistamines, calcineurin inhibitors, antibiotics, immunomodulators, and interleukin inhibitors. Corticosteroids are a class of steroid hormones produced by the adrenal cortex in vertebrates, and synthetic versions of these hormones also exist. They can be administered via topical, oral, or injectable routes and are utilized in the treatment of cancer, blood disorders, chronic illnesses, and infectious diseases. These drugs are made available through a variety of channels, including hospitals, retail pharmacies, drug stores, and online or mail-order pharmacies.
Tariffs have increased the cost of imported dermatology drugs and biologics used in the treatment of skin disorders. These impacts are most evident in markets that rely on cross border sourcing for specialty dermatology therapies. Rising tariff related expenses have placed pressure on pricing structures and reimbursement dynamics for branded and generic dermatology products. This has influenced procurement decisions and product availability across hospital and retail channels. However, tariffs are also supporting domestic pharmaceutical manufacturing, local formulation capacity, and stronger regional supply chains over the long term.
The dermatitis market research report is one of a series of new reports from The Business Research Company that provides dermatitis market statistics, including dermatitis industry global market size, regional shares, competitors with a dermatitis market share, detailed dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the dermatitis industry. This dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dermatitis market size has grown steadily in recent years. It will grow from $7.06 billion in 2025 to $7.36 billion in 2026 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to high prevalence of skin disorders, availability of corticosteroids, dermatologist visits growth, environmental triggers, use of antihistamines.
The dermatitis market size is expected to see steady growth in the next few years. It will grow to $8.94 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to innovation in biologics, rising pollution-related skin issues, growth in dermatology clinics, increased self-care awareness, aging population. Major trends in the forecast period include growing use of biologic therapies, rising demand for topical treatments, expansion of immunomodulatory drugs, increased awareness of chronic skin conditions, growth of otc dermatology products.
The rising incidence of dermatitis is expected to drive the growth of the dermatitis market in the coming years. Dermatitis encompasses a group of inflammatory skin disorders marked by redness, itching, and irritation, often triggered by allergens, environmental factors, immune responses, or genetic susceptibility. The increase in dermatitis cases is largely attributed to greater exposure to environmental allergens and irritants in contemporary lifestyles, which provoke immune system overreactions, leading to skin inflammation and barrier disruption. This rise in dermatitis cases fuels the market by boosting demand for effective treatment options, such as topical steroids, calcineurin inhibitors, antihistamines, moisturizers, and advanced biologic therapies designed to reduce inflammation and enhance patient outcomes. For example, in March 2025, the American Pharmacists Association, a US-based professional organization for pharmacists, reported that approximately 33 million Americans were living with at least one food allergy, impacting around 8 percent of children and 11 percent of adults. Consequently, the growing prevalence of dermatitis is supporting the expansion of the dermatitis market.
Major companies operating in the dermatitis market are developing clean-label, steroid-free products such as ARCTIVA to gain a competitive edge and expand their product portfolios. ARCTIVA is a collection of steroid-free skincare products formulated to manage skin conditions like eczema and psoriasis, incorporating the innovative Hydrosurf Glycolipid Technology. For example, in April 2023, Arctiva Wellness, LLC, a US-based company focused on clean-label skincare, launched ARCTIVA, an advanced range of non-prescription, steroid-free skincare solutions designed to effectively treat skin conditions such as eczema and psoriasis. This transformative skincare line combines cutting-edge scientific research with natural, cruelty-free ingredients, along with clinically validated, FDA-approved active components to ensure proven results. Importantly, it is the only product line on the market to feature the revolutionary Hydrosurf Glycolipid Technology, a distinctive blend of fermented ingredients with notable skincare benefits, originally discovered in Antarctica.
In June 2024, Johnson & Johnson, a US-based healthcare company, acquired Proteologix, Inc., for an undisclosed sum. Through this acquisition, Johnson & Johnson intends to enhance its dermatitis treatment portfolio by incorporating Proteologix's innovative dermatologic therapies and proprietary formulations, facilitating the development of advanced solutions for inflammatory skin conditions. Proteologix, Inc. is a US-based biotechnology company focused on dermatology, with a strong track record in the research and development of therapies for dermatitis and related skin disorders.
Major companies operating in the dermatitis market are LEO Pharma AS, Regeneron Pharmaceuticals Inc., Sanofi S.A., Encore Dermatology Inc., Meda Pharmaceuticals Inc., Allergan Plc, Anacor Pharmaceutical Inc., Astellas Pharma Inc., Mylan N.V., Valeant Pharmaceutical Inc., Galderma SA, Connetics Corporation, Fujisawa Pharmaceutical Company Ltd., AbbVie Inc., Valeant Pharmaceuticals International Inc., GlaxoSmithKline plc, Medimmune Inc., Bausch Health Co. Inc., Nestle Skin Health India Pvt. Ltd., Aqua Pharmaceuticals Pvt. Ltd., Biofrontera AG, Zydus Lifesciences Limited
North America was the largest region in the dermatitis market in 2025. Middle East is expected to be the fastest-growing region in the dermatitis market report during the forecast period. The regions covered in the dermatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The dermatitis market consists of sales of Stasis dermatitis, atopic dermatitis, and irritant contact dermatitis. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Dermatitis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dermatitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Drug Class: Corticosteroids; Emollients Or Moisturizers; Antihistamines; Calcineurin Inhibitors; Antibiotics; Immunomodulators; Interleukin Inhibitors
2) By Distribution Channel: Hospital; Retail Pharmacies; Drug Stores; Online Or Mail Pharmacies
3) By Application: Atopic Dermatitis; Contact Dermatitis; Seborrheic Dermatitis
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
2) By Emollients Or Moisturizers: Creams; Ointments; Lotions; Gels; Other Emollients Or Moisturizers
3) By Antihistamines: Oral Antihistamines; Topical Antihistamines; Injectable Antihistamines
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.4 Increased Awareness Of Chronic Skin Conditions
4.2.5 Growth Of Otc Dermatology Products
5. Dermatitis Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Dermatology Clinics
5.3 Retail Pharmacies
5.4 Specialty Skin Care Centers
5.5 Online Pharmacies
6. Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Dermatitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Dermatitis Market Size, Comparisons And Growth Rate Analysis
7.3. Global Dermatitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Dermatitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Dermatitis Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Dermatitis Market Segmentation
9.1. Global Dermatitis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Dermatitis Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Topical Immunomodulators, Oral Immunomodulators
9.10. Global Dermatitis Market, Sub-Segmentation Of Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
IL-4 Inhibitors, IL-13 Inhibitors, IL-31 Inhibitors, Other Interleukin Inhibitors
10. Dermatitis Market Regional And Country Analysis
10.1. Global Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Dermatitis Market
11.1. Asia-Pacific Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Dermatitis Market
12.1. China Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Dermatitis Market
13.1. India Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Dermatitis Market
14.1. Japan Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Dermatitis Market
15.1. Australia Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Dermatitis Market
16.1. Indonesia Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Dermatitis Market
17.1. South Korea Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Dermatitis Market
18.1. Taiwan Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Dermatitis Market
19.1. South East Asia Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Dermatitis Market
20.1. Western Europe Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Dermatitis Market
21.1. UK Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Dermatitis Market
22.1. Germany Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Dermatitis Market
23.1. France Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Dermatitis Market
24.1. Italy Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Dermatitis Market
25.1. Spain Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Dermatitis Market
26.1. Eastern Europe Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Dermatitis Market
27.1. Russia Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Dermatitis Market
28.1. North America Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Dermatitis Market
29.1. USA Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Dermatitis Market
30.1. Canada Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Dermatitis Market
31.1. South America Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Dermatitis Market
32.1. Brazil Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Dermatitis Market
33.1. Middle East Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Dermatitis Market
34.1. Africa Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Dermatitis Market, Segmentation By Drug Class, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Dermatitis Market Regulatory and Investment Landscape
36. Dermatitis Market Competitive Landscape And Company Profiles
36.1. Dermatitis Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Dermatitis Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Dermatitis Market Company Profiles
36.3.1. LEO Pharma AS Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Encore Dermatology Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Meda Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Dermatitis Market Other Major And Innovative Companies
Allergan Plc, Anacor Pharmaceutical Inc., Astellas Pharma Inc., Mylan N.V., Valeant Pharmaceutical Inc., Galderma SA, Connetics Corporation, Fujisawa Pharmaceutical Company Ltd., AbbVie Inc., Valeant Pharmaceuticals International Inc., GlaxoSmithKline plc, Medimmune Inc., Bausch Health Co. Inc., Nestle Skin Health India Pvt. Ltd., Aqua Pharmaceuticals Pvt. Ltd.
38. Global Dermatitis Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Dermatitis Market
40. Dermatitis Market High Potential Countries, Segments and Strategies
40.1 Dermatitis Market In 2030 - Countries Offering Most New Opportunities
40.2 Dermatitis Market In 2030 - Segments Offering Most New Opportunities
40.3 Dermatitis Market In 2030 - Growth Strategies
